Detailed answers about NEMAURA PHARMA LIMITED, including incorporation, status, business activity, and accounts information.
When was NEMAURA PHARMA LIMITED founded?
NEMAURA PHARMA LIMITED was officially incorporated on 25 November 2005 and is registered under company number 05636878. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEMAURA PHARMA LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEMAURA PHARMA LIMITED?
NEMAURA PHARMA LIMITED's current status is Liquidation. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEMAURA PHARMA LIMITED do?
NEMAURA PHARMA LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is NEMAURA PHARMA LIMITED's registered address?
The registered office address of NEMAURA PHARMA LIMITED is 1ST FLOOR, FAIRCLOUGH HOUSE, CHURCH STREET, CHORLEY, ENGLAND, PR7 4EX. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEMAURA PHARMA LIMITED financially stable?
The most recent accounts for NEMAURA PHARMA LIMITED were made up to 31 March 2023, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2024.
Does NEMAURA PHARMA LIMITED have any charges or mortgages?
NEMAURA PHARMA LIMITED has 1 registered charge, of which 0 are outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.